Lupin

Lupin Overview

Founded 1968
Founded
Status Public
Employees 17,684
Employees
Stock Symbol 500257
Stock Symbol
Investments 24
Share Price $11.94 (As of Tuesday Closing)

Lupin General Information

Description

Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The vast majority of the company's sales are derived from its Advance Markets Formulations segment, followed by Domestic Formulations. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Delivery
Stock Exchange
BOM
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lupin Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.94 $11.77 $6.70 - $12.11 $5.41B 453M 145K -$0.12

Lupin Financials Summary

In Thousands,
USD
TTM 31-Dec-2019 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018 FY 2017 31-Mar-2017
EV 5,363,623 5,559,595 5,932,705 10,778,856
Revenue 2,454,186 2,352,133 2,414,636 2,536,480
EBITDA 336,830 400,575 274,845 680,315
Net Income (52,400) 86,659 38,972 381,272
Total Assets 4,024,430 4,040,506 4,102,843
Total Debt 0 1,223,361 1,097,134 1,228,371
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lupin Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lupin‘s full profile, request access.

Request a free trial

Lupin Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Ajanta Pharma Corporation Mumbai, India 0000
000000000 000000 Corporation Hyderabad, India 00000 00000 000000000 00000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
0000000 0000000000 Corporation Ahmedabad, India 00000 0000 00000000000 0000
00000 Corporation Mumbai, India 00000 00000000

Lupin Executive Team (21)

Name Title Board Seat Contact Info
Vinita Gupta Chief Executive Officer & Board Member
Vinod Dhawan President Asia Africa Middle East and Latin America
Krunal Parekh General Manager, Operations (APAC & Japan), Business Development, Mergers and Acquisitions
Nilesh Gupta Managing Director
Alan Butcher Chief Corporate Development Officer

9 Former Executives

Lupin Board Members (9)

To view Lupin‘s full board member team, request access >>
Name Representing Role Since
000000 000000 Self Independent Director 000 0000
0000-000 000000000 Self Independent Director 000 0000
00000 000000 00.0 Lupin Vice Chairman 000 0000
0. 0. 0000 00.0 Self Independent Director 000 0000
0 0 00000 Self Independent Director 000 0000

1 Former Board Member

Lupin Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lupin‘s full profile, request access.

Request a free trial

Lupin Investments & Acquisitions (24)

To view Lupin‘s complete investment and acquisition history, request access >>
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 11-Oct-2017 000000000000000000 00000 Drug Discovery 000000 00000
00000000 & 0000000 03-Aug-2016 000000000 00000 00 00000 Biotechnology 000000 00000
0000000 00000'0 (0 24-Jul-2015 000000000000000000 Medical Supplies 000000 00000
00000 000000000000 23-Jul-2015 000000000000000000 00000 Pharmaceuticals 000000 00000
Novel Laboratories 23-Jul-2015 Merger/Acquisition Pharmaceuticals 000000 00000

Ready to get started?

Request a free trial

Lupin Subsidiaries (8)

Company Name Industry Location Founded
Symbiomix Therapeutics Drug Discovery Newark, NJ 2012
00000 000000000000 Pharmaceuticals Franklin Township, NJ 0000
00000 000000000000 Pharmaceuticals Franklin Township, NJ 0000
0000000 000000 Distributors (Healthcare) Camberwell, Australia 0000
000000 Drug Delivery Oldenzaal, Netherlands 0000

Lupin Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 10-Oct-2007 0000000000 Completed
  • 2 buyers